Citizens JMP Sticks to Their Buy Rating for ProQR (PRQR)
Citizens JMP analyst Jonathan Wolleben reiterated a Buy rating on ProQR today and set a price target of $8.00. The company’s shares closed yesterday at $2.46.Elevate Your Investing Strategy: Take advantage...
ProQR Therapeutics Appoints Dr. Peter Beal as Chief ADAR Scientist to Advance RNA Editing Platform
ProQR Therapeutics appoints Dr. Peter Beal as Chief ADAR Scientist to enhance RNA editing technology development.Quiver AI SummaryProQR Therapeutics has appointed Dr. Peter Beal, a prominent expert in...
Best Momentum Stocks to Buy for October 2nd
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 2:BRF S.A. BRFS: This meat processing company has a Zacks Rank #1 and witnessed the Zacks...